ReviewPharmaceutics2022
Chitosan Nanoparticles in Atherosclerosis-Development to Preclinical Testing.
Pornsak Sriamornsak et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
5 papers cite it
this papercites it
ReviewPharmaceutics2022
Pornsak Sriamornsak et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.